av/hikma-pharmaceuticals--big.svg

COM:HIKMA

Hikma Pharmaceuticals

  • Stock

Last Close

1,872.00

22/11 10:23

Market Cap

40.38M

Beta: -

Volume Today

12.54K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
274.12M
-
274.50M
0.14%
262M
4.55%
355M
35.50%
473.50M
33.38%
508M
7.29%
548M
7.87%
662.50M
20.89%
726M
9.58%
735.50M
1.31%
833.50M
13.32%
average payables
115.30M
-
124.50M
7.98%
134M
7.63%
155.50M
16.04%
195M
25.40%
240.50M
23.33%
368M
53.01%
471.50M
28.13%
366M
22.38%
276.50M
24.45%
429.50M
55.33%
average receivables
390.46M
-
453.50M
16.15%
494M
8.93%
649.50M
31.48%
766M
17.94%
794.50M
3.72%
812M
2.20%
797.50M
1.79%
836M
4.83%
859.50M
2.81%
863.50M
0.47%
book value per share
5.16
-
6.05
17.10%
6.72
11.13%
10.28
53.06%
6.31
38.65%
6.99
10.83%
8.75
25.12%
9.05
3.41%
10.62
17.38%
9.53
10.24%
9.88
3.71%
capex per share
-0.38
-
-0.60
56.54%
-0.69
15.52%
-0.82
18.45%
-0.63
22.84%
-0.58
8.33%
-0.77
33.26%
-0.95
23.49%
-0.99
4.44%
-1.00
1.32%
-0.92
8.67%
capex to depreciation
-1
-
-1.64
63.89%
-1.88
14.51%
-1.30
30.66%
-0.12
90.65%
-1.15
844.11%
-1.88
63.55%
-2.46
31.02%
-1.58
35.84%
-1.17
26.18%
-0.79
32.44%
capex to operating cash flow
-0.22
-
-0.28
24.76%
-0.37
34.82%
-0.65
73.24%
-0.34
47.44%
-0.32
5.16%
-0.39
21.91%
-0.48
22.51%
-0.36
25.65%
-0.42
18.27%
-0.34
20.96%
capex to revenue
-0.05
-
-0.08
44.23%
-0.10
20.05%
-0.10
2.41%
-0.08
19.95%
-0.07
13.91%
-0.08
25.51%
-0.10
13.54%
-0.09
6.26%
-0.09
0.34%
-0.07
20.62%
cash per share
1.03
-
1.61
57.12%
3.01
86.83%
0.75
75.05%
1.04
38.14%
1.23
18.78%
1.92
55.92%
1.47
23.48%
1.95
32.49%
1.30
33.08%
0.92
29.28%
days of inventory on hand
167.62
-
156.18
6.82%
147.29
5.69%
173.79
17.99%
183.82
5.77%
188.94
2.79%
195.77
3.61%
242.37
23.81%
202.62
16.40%
221.45
9.30%
219
1.11%
days payables outstanding
72.88
-
73.80
1.27%
81.57
10.52%
65.12
20.16%
82.12
26.09%
94.11
14.61%
163.03
73.22%
150.48
7.69%
76.38
49.24%
83.05
8.72%
139.61
68.11%
days sales outstanding
120.33
-
112.02
6.90%
134.59
20.15%
143.75
6.81%
144.04
0.20%
145.47
0.99%
132.14
9.16%
124.11
6.08%
125.24
0.91%
122.25
2.39%
112.23
8.19%
debt to assets
0.23
-
0.25
8.96%
0.28
12.28%
0.20
29.68%
0.23
16.35%
0.18
20.57%
0.17
4.31%
0.23
29.31%
0.19
14.15%
0.29
48.30%
0.25
11.32%
debt to equity
0.43
-
0.47
8.03%
0.54
15.97%
0.36
34.08%
0.51
42.98%
0.38
26.34%
0.32
14.41%
0.44
34.91%
0.34
20.99%
0.60
74.24%
0.54
9.83%
dividend yield
0.01
-
0.01
9.13%
0.01
4.44%
0.01
50.63%
0.02
50.24%
0.02
25.03%
0.02
4.06%
0.01
12.35%
0.02
28.88%
0.03
71.34%
0.03
8.95%
earnings yield
0.05
-
0.05
15.51%
0.04
18.64%
0.03
22.99%
-0.23
896.45%
0.05
123.58%
0.08
43.19%
0.05
30.83%
0.06
14.35%
0.04
26.55%
0.04
16.04%
enterprise value
4.20B
-
6.37B
51.79%
6.96B
9.23%
6.12B
12.01%
4.25B
30.59%
5.61B
31.98%
6.56B
16.94%
8.71B
32.74%
7.34B
15.73%
5.22B
28.88%
6.05B
15.90%
enterprise value over ebitda
9.86
-
13.50
36.99%
14.38
6.52%
11.49
20.10%
2.70
76.51%
11.59
329.48%
9.96
14.11%
13.36
34.16%
9.99
25.25%
7.46
25.32%
6.95
6.85%
ev to operating cash flow
12.46
-
14.99
20.36%
19.02
26.84%
20.90
9.92%
9.60
54.09%
13.05
35.97%
13.90
6.54%
18.77
35.02%
11.50
38.71%
9.85
14.39%
9.95
1.03%
ev to sales
3.08
-
4.28
39.15%
4.83
12.95%
3.14
35.02%
2.20
30.09%
2.71
23.43%
2.97
9.68%
3.72
25.14%
2.87
22.73%
2.07
27.86%
2.10
1.47%
free cash flow per share
1.33
-
1.55
16.58%
1.15
25.78%
0.44
61.59%
1.22
175.23%
1.21
0.76%
1.18
2.12%
1.02
13.95%
1.77
74.11%
1.36
23.10%
1.82
33.43%
free cash flow yield
0.07
-
0.05
24.50%
0.03
33.05%
0.02
43.69%
0.08
315.15%
0.06
29.74%
0.05
18.34%
0.03
34.54%
0.06
99.50%
0.07
22.66%
0.08
10.04%
graham net net
-1.10
-
-1.20
8.30%
-0.61
48.62%
-4.17
578.72%
-3.31
20.65%
-2.57
22.21%
-1.87
27.31%
-2.82
50.50%
-1.95
30.74%
-4.51
131.37%
-5.21
15.36%
graham number
11.18
-
13.82
23.61%
13.84
0.12%
12.41
10.33%
22.33
79.97%
13.57
39.24%
19.88
46.54%
19.28
3.02%
20.87
8.23%
13.42
35.71%
13.79
2.75%
income quality
1.13
-
1.17
3.82%
1.15
1.97%
1.40
21.23%
-0.60
143.02%
1.47
344.49%
0.96
34.50%
0.83
13.50%
1.17
41.04%
2.27
93.95%
2.16
4.88%
intangibles to total assets
0.23
-
0.27
15.41%
0.23
12.60%
0.39
68.57%
0.23
41.19%
0.22
5.46%
0.21
3.12%
0.21
0.17%
0.20
3.69%
0.25
23.22%
0.24
6.51%
interest coverage
9.51
-
10.58
11.20%
6.68
36.82%
2.90
56.56%
-12.45
528.74%
4.64
137.25%
7.36
58.67%
8.39
14.04%
8.43
0.52%
6.58
21.94%
4.08
38.07%
interest debt per share
2.43
-
3.03
24.63%
3.94
30.18%
4.14
4.88%
3.49
15.71%
2.98
14.69%
3.11
4.45%
4.24
36.50%
3.96
6.61%
6.07
53.28%
5.76
5.12%
inventory turnover
2.18
-
2.34
7.32%
2.48
6.04%
2.10
15.25%
1.99
5.45%
1.93
2.71%
1.86
3.49%
1.51
19.23%
1.80
19.62%
1.65
8.51%
1.67
1.12%
invested capital
0.43
-
0.47
8.03%
0.54
15.97%
0.36
34.08%
0.51
42.98%
0.38
26.34%
0.32
14.41%
0.44
34.91%
0.34
20.99%
0.60
74.24%
0.54
9.83%
market cap
3.92B
-
6.09B
55.20%
6.79B
11.41%
5.42B
20.13%
3.70B
31.71%
5.25B
41.84%
6.32B
20.36%
8.10B
28.20%
6.92B
14.58%
4.21B
39.20%
5.06B
20.37%
net current asset value
2M
-
-22M
1,200%
115M
622.73%
-504M
538.26%
-286M
43.25%
-132M
53.85%
47M
135.61%
-65M
238.30%
189M
390.77%
-324M
271.43%
-371M
14.51%
net debt to ebitda
0.64
-
0.60
7.11%
0.36
39.48%
1.32
265.82%
0.35
73.60%
0.75
113.59%
0.37
50.56%
0.93
153.31%
0.57
38.82%
1.45
153.25%
1.13
21.77%
net income per share
1.08
-
1.40
30.47%
1.27
9.81%
0.67
47.47%
-3.51
628.01%
1.17
133.31%
2.01
71.63%
1.83
9.06%
1.82
0.21%
0.84
53.95%
0.85
1.81%
operating cash flow per share
1.71
-
2.15
25.48%
1.84
14.32%
1.26
31.63%
1.85
46.78%
1.78
3.34%
1.95
9.31%
1.97
0.80%
2.76
40.48%
2.37
14.33%
2.73
15.56%
payables turnover
5.01
-
4.95
1.25%
4.47
9.52%
5.60
25.25%
4.44
20.69%
3.88
12.75%
2.24
42.27%
2.43
8.34%
4.78
97.01%
4.40
8.02%
2.61
40.52%
receivables turnover
3.03
-
3.26
7.41%
2.71
16.77%
2.54
6.37%
2.53
0.20%
2.51
0.98%
2.76
10.09%
2.94
6.47%
2.91
0.90%
2.99
2.45%
3.25
8.93%
research and ddevelopement to revenue
0.03
-
0.04
29.28%
0.03
32.32%
0.08
207.69%
0.06
22.78%
0.07
19.55%
0.07
4.29%
0.06
13.89%
0.06
4.29%
0.06
2.14%
0.05
9.41%
return on tangible assets
0.14
-
0.17
17.85%
0.13
24.89%
0.06
53.71%
-0.32
652.44%
0.10
131.88%
0.16
52.02%
0.13
15.75%
0.12
8.52%
0.06
53.57%
0.05
5.51%
revenue per share
6.93
-
7.52
8.53%
7.24
3.78%
8.37
15.66%
8.07
3.61%
8.59
6.48%
9.12
6.18%
9.92
8.77%
11.05
11.42%
11.24
1.67%
12.93
15.06%
roe
0.21
-
0.23
11.41%
0.19
18.84%
0.06
65.68%
-0.56
960.71%
0.17
130.06%
0.23
37.17%
0.20
12.06%
0.17
14.98%
0.09
48.69%
0.09
1.83%
roic
0.17
-
0.18
1.81%
0.15
17.02%
0.07
52.44%
-0.37
629.91%
0.15
141.88%
0.17
10.76%
0.14
16.84%
0.13
6.23%
0.12
10.32%
0.07
39.09%
sales general and administrative to revenue
0.11
-
0.12
12.31%
0.13
0.61%
0.11
14.67%
0.12
15.25%
0.12
3.33%
0.20
-
0.19
3.56%
0.20
5.80%
0.19
6.43%
shareholders equity per share
5.16
-
6.05
17.10%
6.72
11.13%
10.28
53.06%
6.31
38.65%
6.99
10.83%
8.75
25.12%
9.05
3.41%
10.62
17.38%
9.53
10.24%
9.88
3.71%
stock based compensation to revenue
0.01
-
0.01
4.77%
0.01
93.88%
0.01
8.31%
0.01
0.72%
0.01
10.72%
0.01
7.19%
0.01
6.06%
0.01
1.51%
0.01
23.05%
0.01
0.51%
tangible asset value
587M
-
614M
4.60%
745M
21.34%
692M
7.11%
743M
7.37%
931M
25.30%
1.29B
39.10%
1.27B
1.78%
1.57B
23.82%
1.02B
34.98%
1.11B
8.30%
tangible book value per share
2.98
-
3.10
4.07%
3.74
20.73%
2.97
20.67%
3.10
4.24%
3.86
24.78%
5.35
38.52%
5.39
0.72%
6.82
26.50%
4.57
32.95%
4.99
9.10%
working capital
311M
-
172M
44.69%
768M
346.51%
530M
30.99%
777M
46.60%
775M
0.26%
377M
51.35%
894M
137.14%
1.08B
20.58%
922M
14.47%
761M
17.46%

All numbers in (except ratios and percentages)